Pro-inflammatory enzyme and mediator pathways

Pro-inflammatory enzyme and mediator pathways represent a broad category of biochemical signaling routes and enzymatic processes that drive the inflammatory response in biological systems. Key components include the arachidonic acid metabolism pathway, involving enzymes like cyclooxygenase (COX) and lipoxygenase (LOX), as well as the production of various cytokines and chemokines such as tumor necrosis factor-alpha (TNF-α) and interleukins (StatPearls, 2023). These pathways are critical for host defense against pathogens and tissue repair; however, their chronic or excessive activation is a primary driver of inflammatory and autoimmune diseases like rheumatoid arthritis and asthma (Nature Reviews Immunology, 2017). Pharmacological strategies often focus on specific nodes within these pathways, such as using NSAIDs to inhibit prostaglandin synthesis or biologics to neutralize specific inflammatory mediators (NIH, 2022). Because this term encompasses a wide variety of distinct molecular targets rather than a single entity, it is generally classified as a pathway group rather than a specific therapeutic target.

Other names

Inflammatory signaling pathwaysPro-inflammatory cascadeMediators of inflammation

Inhibition of pro-inflammatory enzymes (e.g., COX-1, COX-2, 5-LOX) or antagonism/neutralization of inflammatory mediators (e.g., TNF-alpha, Interleukins, Leukotrienes).